We are live on ! Find out more
KRON

Kronos Bio
KRON

Delisted

KRON was delisted on the 20th of June, 2025.

Back to rankings

77 hedge funds and large institutions have $956M invested in Kronos Bio in 2021 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 34 increasing their positions, 12 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

183% more repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 12

55% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 11

8% more funds holding

Funds holding: 71 → 77 (+6)

6.85% more ownership

Funds ownership: 64.27% → 71.11% (+6.8%)

9% less capital invested

Capital invested by funds: $1.05B → $956M (-$93.5M)

25% less funds holding in top 10

Funds holding in top 10: 4 → 3 (-1)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $2K

Holders
77
Holders Change
+6
Holders Change %
+8.45%
% of All Funds
1.34%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.05%
New
17
Increased
34
Reduced
12
Closed
11
Calls
–
Puts
$2K
Net Calls
-$2K
Net Calls Change
-$2K

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$38M
2
BlackRock
BlackRock
New York
+$30M
3
Capital World Investors
Capital World Investors
California
+$29.5M
4
CIA
Choate Investment Advisors
Massachusetts
+$9.03M
5
State Street
State Street
Massachusetts
+$8.07M

Top Sellers

Rank Fund Capital Flow
1
Capital Research Global Investors
Capital Research Global Investors
California
-$18.9M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$8.6M
3
PA
Perceptive Advisors
New York
-$6.38M
4
Invesco
Invesco
Georgia
-$5.91M
5
HA
HHLR Advisors
Cayman Islands
-$5.7M
Name Holding Trade Value Shares
Change 		Change in
Stake
Northern Trust
26
Northern Trust
Illinois
$7.8M +$4.13M +163,311 +101%
CC
27
Commodore Capital
New York
$7.16M – – –
Franklin Resources
28
Franklin Resources
California
$5.17M +$403K +15,900 +8%
CBA
29
Coastal Bridge Advisors
Connecticut
$4.75M +$2.9M +114,635 New
Morgan Stanley
30
Morgan Stanley
New York
$4.13M +$1.79M +70,593 +69%
BP
31
BBR Partners
New York
$3.92M +$4.15M +163,789 New
N
32
Nuveen
North Carolina
$3.88M +$2.75M +108,487 +203%
UBS AM
33
UBS AM
Illinois
$3.5M -$137K -5,428 -4%
OCA
34
Octagon Capital Advisors
New York
$3.5M – – –
Charles Schwab
35
Charles Schwab
California
$3.5M +$1.28M +50,690 +53%
Bank of New York Mellon
36
Bank of New York Mellon
New York
$2.71M +$1.89M +74,750 +194%
PAMU
37
Pictet Asset Management (UK)
United Kingdom
$2.61M +$163K +6,434 +6%
SB
38
Samsara BioCapital
California
$1.87M -$2.23M -88,119 -53%
California State Teachers Retirement System (CalSTRS)
39
California State Teachers Retirement System (CalSTRS)
California
$1.28M +$782K +30,898 +137%
B
40
Bailard
California
$1.21M +$489K +19,300 +62%
RhumbLine Advisers
41
RhumbLine Advisers
Massachusetts
$1.2M +$887K +35,056 +231%
State of Wisconsin Investment Board
42
State of Wisconsin Investment Board
Wisconsin
$1.17M +$1.24M +49,006 New
Marshall Wace
43
Marshall Wace
United Kingdom
$1.16M +$1.23M +48,616 New
TD Asset Management
44
TD Asset Management
Ontario, Canada
$1.12M +$555K +21,936 +67%
Ameriprise
45
Ameriprise
Minnesota
$944K +$86.2K +3,406 +9%
AllianceBernstein
46
AllianceBernstein
Tennessee
$941K +$995K +39,300 New
Swiss National Bank
47
Swiss National Bank
Switzerland
$889K +$939K +37,100 New
New York State Common Retirement Fund
48
New York State Common Retirement Fund
New York
$801K +$512K +20,230 +153%
Cerity Partners
49
Cerity Partners
New York
$719K – – –
Goldman Sachs
50
Goldman Sachs
New York
$674K +$245K +9,684 +52%
1
2
3 4

KRON Hedge Fund Activity: Q2 2021 in Review

77 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Kronos Bio (KRON) for Q2 2021, worth a combined $956M — down 8.9% from $1.05B a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new KRON positions and 11 closed out — a net gain of 6 holders — while 34 added to existing stakes and 12 trimmed.

The largest buyer was Vanguard Group, adding an estimated $38M. The largest seller was Capital Research Global Investors, cutting an estimated $18.9M.

  • 77 institutional investors held Kronos Bio (KRON) as of Q2 2021, up from 71 in Q1 2021.
  • Funds reported $956M of Kronos Bio stock for Q2 2021, down 8.9% quarter-over-quarter.
  • 17 funds opened new Kronos Bio positions in Q2 2021 and 11 closed out, a net change of +6 holders.
  • The largest Kronos Bio buyer in Q2 2021 was Vanguard Group, an estimated $38M added.
  • The largest Kronos Bio seller in Q2 2021 was Capital Research Global Investors, an estimated $18.9M sold.

Based on aggregated 13F filings for Q2 2021.